Compound Information | |
---|---|
ID | 306 |
TrivialName | Vinaginsenoside R12 |
Type | C17-side chain varied |
MF | C₃₆H₆₄O₁₁ |
MolecularWeight | 672.897 |
IUPACName | 2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(2,5,6-trihydroxy-6-methylheptan-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
m/z | NT |
Retention Time | NT |
CCS | NT |
Adducts | NT |
Isomeric SMILES | CC(O)(C)C(O)CC[C@](C)(O[H])C1CC[C@@]2(C)[C@]3(C)C[C@H](O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)C5C(C)(C)[C@@H](O[H])CC[C@]5(C)C3C[C@@H](O)C21 |
Canonical SMILES | CC(C)(O)C(O)CCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(OC3OC(CO)C(O)C(O)C3O)CC12C |
Source | PV |
Functions | anti-cancer |
Year | 1994 |
References | |
Structure |
|